2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
186
Myelodysplastic Syndromes
82
Leukemia
39
Leukemia, Myelomonocytic, Chronic
36
Recurrence
24
Myeloproliferative Disorders
15
Congenital Abnormalities
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Large B-Cell, Diffuse
13
Neoplasms
11
Primary Myelofibrosis
9
Melanoma
9
Blast Crisis
9
Thrombocythemia, Essential
7
Polycythemia Vera
7
Leukemia, Myelomonocytic, Acute
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Monocytic, Acute
7
Hodgkin Disease
7
Carcinoma, Non-Small-Cell Lung
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Ovarian Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
6
Anemia, Refractory, with Excess of Blasts
6
Neoplasm Metastasis
5
Lymphoma
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Biphenotypic, Acute
5
Lymphoma, Non-Hodgkin
4
Lung Neoplasms
4
Interventions
pembrolizumab
24
Nivolumab
23
aldesleukin
21
Cyclophosphamide
20
Ipilimumab
17
Interleukin-2
17
fludarabine
15
fludarabine phosphate
14
cemiplimab
12
Radiotherapy
7
Fluorouracil
7
Biopsy
7
dabrafenib
6
Surveys and Questionnaires
6
Dacarbazine
6
trametinib
5
binimetinib
5
Vemurafenib
5
Temozolomide
5
Surgical Procedures, Operative
5
Sirolimus
5
Radiation
5
Blood Specimen Collection
5
Aminolevulinic Acid
5
sonidegib
4
encorafenib
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Educational Status
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Decitabine
×
Clear all
NCT00715793
2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2
Completed
39 enrolled
12 charts